2 Division of Rheumatology, University of British Columbia, Vancouver, Canada 3 Centre for Health Evaluation and Outcomes Sciences, Providence Health, University of British Columbia, Vancouver, Canada ...
1 Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands 2 Department of Rheumatology, VU University Medical Center, Amsterdam, The Netherlands 3 Department of Molecular ...
Background While several studies have reported a link between the presence of gout and adverse cardiovascular (CV) events in the general population, none has addressed the question of whether the ...
Background: We have previously found promise in NMR as a tool to distinguish sera of active from inactive inflammatory myositis (IIM)1. To understand the changes previously found in sera and urine we ...
Objective: To evaluate the long-term effectiveness and tolerability of adalimumab in the treatment of psoriatic arthritis (PsA). Methods: Patients with PsA who completed a 24-week, double-blind study ...
A substantial and persuasive body of data now exists that supports the view that integrin alpha V beta 3 plays a critical part in activated macrophage dependent inflammation, osteoclast development, ...
Objective: To conduct a cross-sectional review of non-selected consecutive outpatients with rheumatoid arthritis (RA) as part of standard clinical care in 15 countries for an overview of the ...
Correspondence to Alberto Martini, University of Genoa, Pediatria II, Istituto G Gaslini, Largo Gaslini 5, Genova 16147, Italy; albertomartini{at}ospedale-gaslini.ge.it Juvenile idiopathic arthritis ...
41 St. Joseph's Health Care London and University of Western Ontario, London, Ontario, Canada Objective The 1980 American College of Rheumatology (ACR) classification criteria for systemic sclerosis ...
Background Celastrol, a pentacyclic-triterpene isolated from Tripterigium wilfordii roots, has shown great therapeutic potential for the treatment of several inflammatory diseases, including ...
Objectives The systemic vasculitides are multiorgan diseases where early diagnosis and treatment can significantly improve outcomes. Robust nomenclature reduces diagnostic delay. However, key aspects ...
Correspondence to Dr Adi Diab, Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center FC3004, 1515 Holcombe Blvd Houston, Texas; adiab{at}mdanderson.org Background Immune ...